France Investment (china 1) Group Limited - Net Worth and Insider Trading

France Investment (china 1) Group Limited Net Worth

The estimated net worth of France Investment (china 1) Group Limited is at least $5.9 Billion dollars as of 2024-06-23. France Investment (china 1) Group Limited is the 2101 Beneficial owner of Sino Biopharmaceutical Ltd and owns about 2,279,254,761 shares of Sino Biopharmaceutical Ltd (HKSE:01177) stock worth over $5.9 Billion. Details can be seen in France Investment (china 1) Group Limited's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that France Investment (china 1) Group Limited has not made any transactions after 2020-08-03 and currently still holds the listed stock(s).

Transaction Summary of France Investment (china 1) Group Limited

France Investment (china 1) Group Limited Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, France Investment (china 1) Group Limited owns 1 companies in total, including Sino Biopharmaceutical Ltd (HKSE:01177) .

Click here to see the complete history of France Investment (china 1) Group Limited’s form 4 insider trades.

Insider Ownership Summary of France Investment (china 1) Group Limited

Ticker	Comapny	Transaction Date	Type of Owner
HKSE:01177	Sino Biopharmaceutical Ltd	2020-08-03	2101 Beneficial owner

France Investment (china 1) Group Limited Latest Holdings Summary

France Investment (china 1) Group Limited currently owns a total of 1 stock. France Investment (china 1) Group Limited owns 2,279,254,761 shares of Sino Biopharmaceutical Ltd (HKSE:01177) as of August 3, 2020, with a value of $5.9 Billion.

Latest Holdings of France Investment (china 1) Group Limited

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:01177	Sino Biopharmaceutical Ltd	2020-08-03	2,279,254,761	2.60	5,926,062,379

Holding Weightings of France Investment (china 1) Group Limited

France Investment (china 1) Group Limited Form 4 Trading Tracker

According to the SEC Form 4 filings, France Investment (china 1) Group Limited has made a total of 1 transactions in Sino Biopharmaceutical Ltd (HKSE:01177) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Sino Biopharmaceutical Ltd is the sale of 759,751,587 shares on August 3, 2020, which brought France Investment (china 1) Group Limited around $0.

Insider Trading History of France Investment (china 1) Group Limited

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

France Investment (china 1) Group Limited Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

France Investment (china 1) Group Limited Ownership Network

Ownership Network List of France Investment (china 1) Group Limited

No Data

Ownership Network Relation of France Investment (china 1) Group Limited

France Investment (china 1) Group Limited Owned Company Details

What does Sino Biopharmaceutical Ltd do?

Who are the key executives at Sino Biopharmaceutical Ltd?

France Investment (china 1) Group Limited is the 2101 Beneficial owner of Sino Biopharmaceutical Ltd. Other key executives at Sino Biopharmaceutical Ltd include 2101 Beneficial owner Tse Eric S Y , 2101 Beneficial owner Tse Ping , and 2101 Beneficial owner Cheng Cheung Ling .

Sino Biopharmaceutical Ltd (HKSE:01177) Insider Trades Summary

Over the past 18 months, France Investment (china 1) Group Limited made no insider transaction in Sino Biopharmaceutical Ltd (HKSE:01177). Other recent insider transactions involving Sino Biopharmaceutical Ltd (HKSE:01177) include a net purchase of 37,000,000 shares made by Tse Ping , a net purchase of 5,000,000 shares made by Tse Eric S Y , and a net purchase of 1,500,000 shares made by Tse Theresa Y Y .

In summary, during the past 3 months, insiders sold 0 shares of Sino Biopharmaceutical Ltd (HKSE:01177) in total and bought 5,000,000 shares, with a net purchase of 5,000,000 shares. During the past 18 months, 0 shares of Sino Biopharmaceutical Ltd (HKSE:01177) were sold and 43,500,000 shares were bought by its insiders, resulting in a net purchase of 43,500,000 shares.

Sino Biopharmaceutical Ltd (HKSE:01177)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sino Biopharmaceutical Ltd Insider Transactions

No Available Data

France Investment (china 1) Group Limited Mailing Address

Above is the net worth, insider trading, and ownership report for France Investment (china 1) Group Limited. Currently GuruFocus does not have mailing address information for France Investment (china 1) Group Limited.

Discussions on France Investment (china 1) Group Limited

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.